Johnson & Johnson (JNJ.US) has increased the settlement amount for the baby powder carcinogenic lawsuit to over $8.2 billion.
According to informed sources, Johnson & Johnson has increased the settlement amount for thousands of lawsuits accusing its baby powder of causing cancer to over $8.2 billion, compared to the previously proposed settlement amount of $6.5 billion.
According to sources familiar with the matter, Johnson & Johnson has increased the settlement amount for thousands of lawsuits alleging its baby powder causes cancer to over $8.2 billion, up from the previous offer of $6.5 billion. The decision to increase the settlement amount will bring the total amount the company has agreed to pay or has already paid to resolve baby powder-related lawsuits to over $13.4 billion.
Sources added that under the new terms, claimants may receive higher compensation as well as approximately $650 million in legal fees. Settlement negotiations are ongoing.
Johnson & Johnson maintains that talcum powder (now discontinued) has never been proven to cause cancer. The company recently obtained agreements from over 75% of the plaintiffs in baby powder-related lawsuits to reach out-of-court settlement agreements.
If more plaintiffs accept the agreement, it will help Johnson & Johnson expedite bankruptcy proceedings, confining liability to a subsidiary established to settle legal claims. The company may reportedly file for bankruptcy in the coming days.
Johnson & Johnson has also resolved 95% of allegations regarding its baby powder being contaminated with asbestos and causing mesothelioma, a type of cancer affecting the lungs, heart, and other organ tissues.
Related Articles

US Stock Market Move | Moderna (MRNA.US) rises more than 7% as data from two new mRNA vaccines show positive results

US Stock Market Move | ZK.US (Extremely Cool) Rises Over 4%, New ZK7X Officially Begins Pre-sale
.png)
US Stock Market Move | Gold concept stocks rise, spot gold surged over 2% intraday.
US Stock Market Move | Moderna (MRNA.US) rises more than 7% as data from two new mRNA vaccines show positive results

US Stock Market Move | ZK.US (Extremely Cool) Rises Over 4%, New ZK7X Officially Begins Pre-sale

US Stock Market Move | Gold concept stocks rise, spot gold surged over 2% intraday.
.png)
RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025